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Abstract
Background: Ethical concerns were identified as a potential barrier to advancing palliative and end-of-life science
at the 2004 National Institutes of Health State of the Science Meeting. However, data are lacking about the nature
of ethical concerns and strategies for balancing the need to advance science with human subjects protections.
Methods: A qualitative case-study design was used to follow 43 end-of-life studies from proposal development
through the review process and implementation. Investigators participated in semi-structured telephone inter-
views and provided document data regarding their experiences with grant and IRB reviews. Using constant
comparative analysis within and across cases, the investigators identified commonly encountered and unique
concerns and strategies for managing these concerns.
Findings: Investigator strategies fell into two broad categories: 1) Recruitment and consent strategies related to
subject identification and enrollment; and 2) Protocol-related strategies related to the process of data collection.
These strategies shared the overarching meta-themes of compassion, as evidenced by a heightened sensitivity to
the needs of the population, coupled with vigilance, as evidenced by close attention to the possible effects of
study participation on the participants’ well-being, clinical care, and the needs of research staff.
Conclusions: Ethical concerns have led to the development of compassionate and vigilant strategies designed to
balance the potential for risk of harm with the need to advance the science of palliative and end-of-life care.
These strategies can be used by investigators to address ethical concerns and minimize barriers to the devel-
opment of palliative and end-of-life care science.
Introduction
The dramatic growth of the aging population in theUnited States has created a pressing need for expansion of
end-of-life care research to explore issues including symptom
management, caregiving, treatments, and outcomes.1–3 Con-
cerns about the ethics of conducting research with patients
near the end of life and their family members represent a
potential barrier to the advancement of science in this area.2,4
The Belmont Report principles of respect for persons (au-
tonomy), beneficence, and justice offer a helpful framework
for organizing these ethical concerns.5 Autonomy-related
concerns are focused on the ability to give informed consent.
This raises questions about decisional capacity, assent, and
proxy decision making.6,7 Of particular concern is whether
individuals near the end of life are able to give voluntary
consent to participation or whether they are overly suscepti-
ble to undue influence because of their poor health or
dependence on treating clinicians.8,9 Beneficence-related
concerns include questions about how to evaluate the risks of
participation in palliative and end-of-life research as the risks
and potential benefits related to participationmay be different
for someone who is healthy than for someone near the end of
life.4,6,8,10 Although there may be no direct personal benefit,
participants may still find meaning in the act of participat-
ing.11,12 Additionally, researchers need to ensure that clinical
needs identified in the course of research are addressed.9,13,14
Justice-related issues include concerns that fair subject selec-
tion and equal opportunity to participate are not possible due
to gatekeeping by organizations, clinicians, or family mem-
bers, which limits investigators’ ability to access potential
subjects who may be interested in participation.2,15 Including
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populations with sensory, mobility, or cognitive impairments
may necessitate adapting methods to accommodate disease-
related limitations to ensure access.16
There are minimal data available about how investigators
manage the ethical challenges described above. The literature
contains accounts of investigators’ experiences with recruit-
ment challenges in palliative and end-of-life care research that
touch on ethical issues.15,17–20 However, only a few articles
explicitly describe investigators’ successful strategies for ad-
dressing ethical issues based on first-hand experiences with
specific populations or settings.21–25 These articles make
important contributions, but given the wide variations in in-
stitutional review board (IRB) evaluation of ethical issues,26
there is a need for more systematic data about investigators’
strategies across the full range of settings and populations
where end-of-life research occurs.
Methods
A qualitative, exploratory case study design was used to
identify and describe investigators’ experiences conducting
palliative and end-of-life care studies. Investigators were
asked about all phases of the study including proposal sub-
mission, grant review, IRB review, and study implementa-
tion. Data sources included telephone interviews with the
case study investigator as well as relevant document data
(e.g., grant reviews, IRB correspondence). Following IRB ap-
proval, a certificate of confidentiality was obtained from the
National Institutes of Health (NIH). Data collection occurred
between August 2009 and July 2010. The focus of this paper is
on strategies used to address ethical concerns raised by in-
vestigators, IRBs, and external reviewers.
Sample selection
Studies selected for potential inclusion were conducted in
the U.S. and focused on social or behavioral issues related to
terminally or seriously ill patients and/or their families. Stu-
dies with active funding were identified using the online NIH
database and private foundation websites. Studies presented
at professional conferences within the prior year were also
eligible for inclusion. Studies were considered ineligible if
data collection was completed before 2005. The search was
narrowed using the same criteria used at the 2004NIH State of
the Science Consensus Conference on Improving Care of the
Dying.27 Case selection was guided by the principle of max-
imum variation to locate studies representing a range of
funding sources, designs, methods, and participant popula-
tions.28 The sample size was based on qualitative research
sampling guidelines regarding scope of the study (focused)
and nature of the topic (concrete), and interviews were con-
tinued until informational redundancy was achieved.29–31
Study procedures
Principal investigators were invited to participate by email.
Investigators who agreed to be contacted were screened by
phone to confirm case study eligibility. Telephone interviews
were conducted by the study team (SH, JC, CN) using a
semistructured, open-ended interview guide. Investigators
were asked about their experiences with ethical issues during
study development, funding, and implementation. Inter-
views lasted approximately an hour although several took
close to two hours. Investigators were invited to submit rel-
evant study documents pertaining to grant or IRB reviews.
Interviews were transcribed verbatim, proofed for accuracy
and removal of identifying information, and organized by
study case using NVivo 8.0.32
Analysis
Analysis was performed concurrently with data collection,
and interview guides were modified based on ideas or ques-
tions that arose during the analysis. Well-established quali-
tative techniques guided analysis of the case data.33–35 Each
case was analyzed using the following processes: open coding
of interview data to inductively identify and label ideas or
experiences, followed by examining the document data to
locate additional ideas or information that elaborated on or
confirmed what was discussed in the interview. Data were
coded line by line.Where available, document data were used
to confirm key ideas that emerged from the interview. After
individual cases were coded, constant comparative analysis
across cases was used to identify overarching themes and
subthemes related to management strategies.29 Themes were
also compared for similarities and differences. Theoretical
memos documented the types of strategies described by in-
vestigators. Demographic data about the participants were
descriptively analyzed.
Verification of the analysis. To ensure consistency in
coding the data, the research team developed a coding
dictionary documenting code definitions and coding deci-
sions related to the application of codes. Each interviewer
separately coded the first 9 interview transcripts and then
discussed differing coding interpretations with the team until
consensus was reached. Following the identification of the
initial code list, the remaining 34 transcripts were each coded
by a primary and a secondary reviewer with discussions at
regularly held team meetings. The code list continued to be
refined during this process. The team met regularly with an
expert methods consultant (KK) who audited the analytical
procedures for overall quality.
Sample
Principal investigators for 74 case studies were contacted
about participation: 43 (58.1%) agreed to participate; 9 (12.2%)
actively refused to participate; 12 (16.2%) passively refused
(by not responding to the invitation emails); and 10 (13.5%)
were determined to be ineligible. Overall, 43/64 (62.7%) of
eligible cases were included in the sample. For three studies, a
second investigator also participated in the interview, re-
sulting in a sample of 46 investigators sharing information
about their experiences with 43 case studies (Tables 1 and 2).
Strategies specific to palliative
and end-of-life care research
The strategies described were largely developed by inves-
tigators either in anticipation of potential ethical concerns or
as a result of prior research experiences. Few strategies were
suggested by IRBs or external reviewers. More-junior inves-
tigators described the benefits of working with experts to
learn relevant strategies; more-experienced investigators re-
ported a process of building a collection of strategies over
STRATEGIES TO MANAGE ETHICAL CONCERNS 881
time. Table 3 contains a list of strategy categories with ex-
emplar quotes and sample strategies used by investigators.
Recruitment and consent strategies
Consent to contact. Investigators reported that they
were generally not allowed by IRBs to directly contact
potential study participants ‘‘cold,’’ due to concerns about
protecting patient confidentiality and a desire to avoid up-
setting individuals during a sensitive time. Instead, the in-
vestigators had to develop strategies that gave potential
participants the option to refuse any contact by the research
team. Consent to contact was sometimes obtained by treating
clinicians, an approach that protected confidentiality, allowed
the clinical partners to confirm study eligibility, and made it
possible to screen out individuals perceived to be too dis-
tressed to participate. However, clinicians who were un-
supportive of the research did not always cooperate in
identifying potential participants or presented the study only
to a select (potentially biased) population of participants. In
some situations, potential participants were sent a letter
from either the investigator or a clinical partner indicating
someone from the study would be in contact. Depending on
the IRB, participants could either opt out of participation (by
indicating they did not wish to be contacted) or opt in
(meaning investigators were only able to call if the participant
provided permission). Opt-outs were perceived as less bur-
densome for potential participants and more successful than
opt-in strategies.
Initial contact. Investigators reported that the timing of
the initial approach had to be carefully considered. In some
cases this required the development of fairly broad eligibility
criteria that allowed participants to decide when they felt
ready to participate, even if it had been many months after
the event under study (e.g., the death of a loved one). In-
vestigators reported that they often employed multiple re-
cruitment approaches within the same study, depending on
the study site and other unique factors; and several described
the importance of modifying recruitment strategies when
accrual was slow. When a referral was received, a rapid re-
sponse was often critical to avoid losing a potential subject
due to declining health.
Consent process and forms. Whereas IRBs were per-
ceived as emphasizing the use of standardized language and
providing comprehensive details about risks and benefits in
consent forms, investigators focused more on presenting in-
formation in ways that reduced burden, prevented distress,
and fit the needs of a population already under duress. When
possible, investigators obtained waivers of documentation of
written consent from the IRB so that consent could be ob-
tained verbally by phone or in person. Alternate versions of
the consent form were provided by some investigators, such
as a one-page summary or brochure that provided an over-
view of the study’s purpose and what participation would
entail. Several investigators described modifying the ap-
proach to obtaining consent so participants had the oppor-
tunity to ask questions about the study prior to enrollment
(e.g., reading the consent form out loud at a deliberate, un-
hurried pace). Some obtained IRB approval for witnessed
consent to help ensure physically impaired persons were able
to participate even if they were unable to sign a form. Other
investigators inserted language in the consent document de-
scribing the intent to report symptoms to clinicians in the
event that clinical care was needed. A related strategy was
providing examples of the most sensitive research questions
in the consent form, so that participants who chose to consent
were fully aware of the nature of the study questions.
Decisional capacity. Patients nearing the end of lifemay
lack decisional capacity or may experience fluctuating and/or
declining capacity. Investigators therefore stressed that it was
important to have clear plans to assess capacity at the time of
consent. In some studies, participants who lacked capacity
were excluded from participation altogether. In other research
it was important to include participants who lacked capacity
to ensure the representativeness of the sample, as loss of
capacity is common near the end of life.36 For these studies,
investigators described working with the IRB to determine
who was viewed as an appropriate proxy and developing a
plan to obtain assent either verbally or in writing from
Table 2. Characteristics of the Case Research Studies
Case studies (n= 43)
Study methodology
Mixed methods 19 (44%)
Qualitative 10 (26%)
Quantitative 13 (30%)
Study design
Descriptive 26 (60.5%)
Intervention 17 (39.5%)
Funding source
Federally funded 26 (61%)
Private foundation 13 (30%)
Other/none 4 (9%)
Study documentation provided (yes) 24 (57%)
Table 1. Characteristics of Participating
Investigators1
Investigator sample (n = 43)
Demographics No. (%)
Female gender 32 (74.4%)
White race 41 (95.3%)
Discipline
Physician 18 (41.9%)
Nurse 16 (37.2%)
Social scientist 7 (16.3%)
Other 2 (4.7%)
Experience in years
0 - 5 9 (20.9%)
6- 15 21 (48.8%)
16-25 13 (30.2%)
Number EOL studies
1-3 12 (27.9%)
4-10 19 (44.2%)
11-30 12 (27.9%)
IRB experience (yes) 12 (27.9%)
Grant review experience (some or lots) 31 (72.1%)
1In three instances a second investigator participated in the
interview, but demographic data was only collected for the primary
interviewee.
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se
n
si
ti
v
e
st
u
d
y
q
u
es
ti
o
n
s
in
th
e
co
n
se
n
t
fo
rm
so
p
ar
ti
ci
p
an
ts
w
h
o
ag
re
e
to
p
ar
ti
ci
p
at
e
m
o
re
fu
ll
y
u
n
d
er
st
an
d
n
at
u
re
o
f
st
u
d
y
.
(c
on
ti
n
u
ed
)
883
T
a
b
l
e
3.
(C
o
n
t
in
u
e
d
)
S
tr
at
eg
y
fo
cu
s
S
tr
at
eg
y
ca
te
g
or
ie
s
E
x
em
p
la
r
p
ar
ti
ci
p
an
t
qu
ot
es
S
am
p
le
st
ra
te
g
ie
s
D
ec
is
io
n
al
ca
p
ac
it
y
:
A
p
p
ro
ac
h
es
to
as
se
ss
in
g
th
e
ca
p
ac
it
y
to
co
n
se
n
t
to
p
ar
ti
ci
p
at
io
n
an
d
id
en
ti
fy
in
g
ap
p
ro
p
ri
at
e
su
rr
o
g
at
es
.
‘‘A
n
d
in
it
ia
ll
y
w
e
al
so
h
ad
a
re
q
u
ir
em
en
t
in
th
er
e
th
at
th
er
e
w
as
‘n
o
n
o
te
d
co
g
n
it
iv
e
im
p
ai
rm
en
t’
fo
r
co
n
se
n
ti
n
g
to
th
e
st
u
d
y
,
b
u
t
w
e
m
o
d
ifi
ed
th
at
so
th
at
w
e
ca
n
en
ro
ll
h
o
sp
ic
e
p
at
ie
n
ts
w
h
o
ar
e
n
o
lo
n
g
er
ab
le
to
p
ro
v
id
e
an
in
fo
rm
ed
co
n
se
n
t,
b
u
t
ca
n
as
se
n
t
to
th
e
st
u
d
y
it
se
lf
.’’
N
01
3J
‘‘W
e
u
se
d
th
e
[I
R
B
]
sc
re
en
in
g
to
o
l,
so
w
e
w
er
e
p
re
p
ar
ed
to
d
ea
l
w
it
h
ca
p
ac
it
y
is
su
es
to
m
ak
e
in
fo
rm
ed
co
n
se
n
t.
W
e
h
ad
a
w
h
o
le
p
ie
ce
o
n
as
se
n
t
as
w
el
l.
If
w
e
d
ec
id
ed
th
at
th
er
e
w
as
so
m
eo
n
e
th
at
w
an
te
d
to
p
ar
ti
ci
p
at
e,
b
u
t
w
e
w
er
e
q
u
es
ti
o
n
in
g
th
ei
r
ca
p
ac
it
y
to
g
iv
e
in
fo
rm
ed
co
n
se
n
t,
w
e
h
ad
th
e
w
h
o
le
as
se
n
t
p
ie
ce
in
p
la
ce
.’’
N
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(a
)
A
ss
es
s
d
ec
is
io
n
al
ca
p
ac
it
y
at
ti
m
e
o
f
en
ro
ll
m
en
t
if
p
o
p
u
la
ti
o
n
is
an
ti
ci
p
at
ed
to
b
e
im
p
ai
re
d
.
(b
)
P
ro
ac
ti
v
el
y
es
ta
b
li
sh
st
an
d
ar
d
s
an
d
p
ro
ce
d
u
re
s
fo
r
p
ro
x
y
co
n
se
n
t,
w
it
n
es
s
co
n
se
n
t,
an
d
as
se
n
t
w
it
h
IR
B
.
P
ro
to
co
l
re
la
te
d
st
ra
te
g
ie
s
A
p
p
ro
ac
h
in
g
a
P
ot
en
ti
al
ly
S
en
si
ti
v
e
T
op
ic
:
S
tr
at
eg
ie
s
to
g
en
tl
y
ap
p
ro
ac
h
a
d
el
ic
at
e
to
p
ic
.
‘‘W
e
w
er
e
at
g
re
at
p
ai
n
s
to
m
ak
e
su
re
th
e
in
te
rv
ie
w
s
w
er
e
al
l
d
o
n
e
in
w
ay
s
th
at
w
er
e
v
er
y
se
n
si
ti
v
e
an
d
w
e
u
se
d
la
n
g
u
ag
e
th
at
g
av
e
p
eo
p
le
an
o
p
p
o
rt
u
n
it
y
to
n
o
t
an
sw
er
o
r
[i
n
d
ic
at
e
th
at
ce
rt
ai
n
to
p
ic
s
d
id
n
o
t
ap
p
ly
to
th
em
]
–
al
l
th
o
se
k
in
d
s
o
f
th
in
g
s.
’’
N
06
9J
‘‘W
e
ar
e
v
er
y
ca
re
fu
l
in
th
e
w
ay
th
at
w
e
w
o
rd
o
u
r
co
n
se
n
t
fo
rm
an
d
o
u
r
q
u
es
ti
o
n
n
ai
re
s
to
tr
y
an
d
m
ak
e
it
cl
ea
r
th
at
in
d
iv
id
u
al
p
at
ie
n
ts
an
d
fa
m
il
ie
s
m
ay
fi
n
d
th
at
so
m
e
o
f
th
es
e
q
u
es
ti
o
n
s
d
o
n
’t
ap
p
ly
to
th
em
,a
n
d
to
so
rt
o
f
g
iv
e
th
em
th
at
p
sy
ch
o
lo
g
ic
al
o
u
t
o
r
p
sy
ch
o
lo
g
ic
al
p
ro
te
ct
io
n
if
th
is
is
st
re
ss
fu
l
fo
r
th
em
.’’
N
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(a
)
U
se
‘‘m
ay
n
o
t
ap
p
ly
’’
q
u
al
ifi
er
s
to
g
iv
e
p
ar
ti
ci
p
an
ts
a
p
sy
ch
o
lo
g
ic
al
‘‘o
u
t’
’
in
co
n
se
n
t
fo
rm
an
d
in
te
rv
ie
w
.
(b
)
U
se
b
ro
ad
,
o
p
en
-e
n
d
ed
q
u
es
ti
o
n
s
th
at
ex
p
an
d
fo
cu
s
an
d
al
lo
w
p
ar
ti
ci
p
an
t
to
d
ec
id
e
w
h
at
as
p
ec
ts
o
f
q
u
es
ti
o
n
ar
e
ap
p
li
ca
b
le
to
th
ei
r
si
tu
at
io
n
.
(c
)
B
e
se
n
si
ti
v
e
an
d
re
sp
o
n
si
v
e
to
cu
es
o
f
d
is
co
m
fo
rt
o
r
h
es
it
at
io
n
.
(d
)
B
ac
k
aw
ay
fr
o
m
o
r
sk
ip
se
n
si
ti
v
e
q
u
es
ti
o
n
s
if
re
sp
o
n
se
s
to
p
re
li
m
in
ar
y
q
u
es
ti
o
n
s
su
g
g
es
t
d
is
co
m
fo
rt
o
r
a
la
ck
o
f
aw
ar
en
es
s.
U
se
of
la
n
g
u
ag
e:
S
el
ec
ti
n
g
la
n
g
u
ag
e
to
av
o
id
in
ad
v
er
te
n
tl
y
d
is
cl
o
si
n
g
p
ro
g
n
o
si
s
o
r
o
th
er
in
fo
rm
at
io
n
th
at
p
ar
ti
ci
p
an
ts
m
ay
n
o
t
al
re
ad
y
k
n
o
w
,
o
r
m
ay
ch
o
o
se
n
o
t
to
re
co
g
n
iz
e.
In
cl
u
d
es
re
cr
u
it
m
en
t,
co
n
se
n
t,
an
d
d
at
a
co
ll
ec
ti
o
n
d
o
cu
m
en
ts
o
r
sp
ee
ch
.
‘‘W
e
ar
e
v
er
y
ca
u
ti
o
u
s
to
k
in
d
o
f
tr
ea
d
li
g
h
tl
y
an
d
as
k
q
u
es
ti
o
n
s
in
a
w
ay
th
at
d
o
es
n
o
t
p
re
su
p
p
o
se
th
at
th
ey
ar
e
aw
ar
e
o
f
th
ei
r
p
ro
g
n
o
si
s.
’’
N
06
4S
‘‘W
e
n
ev
er
ta
lk
ab
o
u
t
en
d
o
f
li
fe
in
o
u
r
st
u
d
ie
s.
W
e
ta
lk
ab
o
u
t
se
ri
o
u
s
il
ln
es
s.
’’
N
06
9J
(a
)
A
v
o
id
ch
ar
g
ed
te
rm
s
in
cl
u
d
in
g
te
rm
in
al
,
d
ea
th
,
d
y
in
g
,
an
d
en
d
o
f
li
fe
.
(b
)
U
se
te
rm
s
su
ch
as
ad
v
an
ce
d
il
ln
es
s,
cr
it
ic
al
ly
il
l,
se
ri
o
u
sl
y
il
l,
p
al
li
at
iv
e
ca
re
,
o
r
li
fe
-l
im
it
in
g
d
is
ea
se
.
(c
)
U
se
la
n
g
u
ag
e
em
p
lo
y
ed
b
y
p
ar
ti
ci
p
an
t
an
d
fo
ll
o
w
th
ei
r
le
ad
o
n
w
h
at
te
rm
s
ar
e
ac
ce
p
ta
b
le
.
(d
)
A
v
o
id
la
n
g
u
ag
e
th
at
co
n
v
ey
s
o
r
d
is
cl
o
se
s
p
ro
g
n
o
st
ic
in
fo
rm
at
io
n
.
(c
on
ti
n
u
ed
)
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(C
o
n
t
in
u
e
d
)
S
tr
at
eg
y
fo
cu
s
S
tr
at
eg
y
ca
te
g
or
ie
s
E
x
em
p
la
r
p
ar
ti
ci
p
an
t
qu
ot
es
S
am
p
le
st
ra
te
g
ie
s
W
or
ki
n
g
w
it
h
cl
in
ic
ia
n
s:
S
tr
at
eg
ie
s
th
at
in
cl
u
d
e
w
o
rk
in
g
w
it
h
cl
in
ic
ia
n
s
as
co
n
su
lt
an
ts
,
sc
re
en
er
s,
o
r
to
ad
d
re
ss
p
h
y
si
ca
l
o
r
em
o
ti
o
n
al
sy
m
p
to
m
s
id
en
ti
fi
ed
d
u
ri
n
g
th
e
st
u
d
y
.
‘‘W
e
w
o
rk
cl
o
se
ly
w
it
h
th
e
o
n
co
lo
g
is
t.
W
e
g
et
a
li
st
fr
o
m
th
em
o
f
th
e
p
at
ie
n
ts
w
h
o
m
ee
t
cr
it
er
ia
,
an
d
th
en
w
e
as
k
th
em
if
th
er
e
ar
e
an
y
sp
ec
ifi
c
p
at
ie
n
ts
th
at
th
ey
fe
el
m
ig
h
t
b
e
h
ar
m
ed
b
y
u
s
ap
p
ro
ac
h
in
g
th
em
.
A
ct
u
al
ly
,
th
ey
w
il
l
o
ft
en
h
av
e
h
el
p
fu
l
in
fo
rm
at
io
n
.
T
h
ey
m
ig
h
t
sa
y
,
y
o
u
k
n
o
w
,
‘T
h
is
p
er
so
n
is
so
il
l
–
I
d
o
n
’t
th
in
k
th
ey
ar
e
g
o
in
g
to
m
ak
e
it
[t
h
ro
u
g
h
]
th
e
w
h
o
le
st
u
d
y
.’
O
r
th
ey
m
ay
g
iv
e
u
s
a
h
ea
d
s
u
p
th
at
th
is
is
a
v
er
y
fr
ag
il
e
p
at
ie
n
t
w
h
o
u
se
s
a
lo
t
o
f
d
en
ia
l
an
d
ev
en
if
ap
p
ro
ac
h
ed
to
b
e
in
v
o
lv
ed
in
a
st
u
d
y
li
k
e
th
is
w
il
l
fr
ea
k
o
u
t
o
r
so
m
et
h
in
g
li
k
e
th
at
.’’
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‘‘A
n
y
sy
m
p
to
m
s
ra
te
d
as
se
v
er
e–
an
d
w
e
u
se
d
a
fo
u
r,
n
o
n
e,
m
il
d
,
m
o
d
er
at
e,
se
v
er
e
L
ik
er
t
sc
al
e
fo
r
as
se
ss
in
g
se
v
er
it
y
o
f
sy
m
p
to
m
s–
b
y
th
e
p
at
ie
n
t
w
o
u
ld
b
e
re
p
o
rt
ed
to
th
e
p
at
ie
n
t’
s
p
ri
m
ar
y
n
u
rs
e
an
d
d
o
cu
m
en
te
d
in
th
e
m
ed
ic
al
re
co
rd
,
an
d
th
at
w
as
ac
ce
p
ta
b
le
to
th
e
st
u
d
y
se
ct
io
n
an
d
to
th
e
IR
B
.’’
N
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(a
)
B
ef
o
re
ap
p
ro
ac
h
in
g
p
at
ie
n
ts
,
se
ek
in
p
u
t
fr
o
m
cl
in
ic
ia
n
s
ab
o
u
t
w
h
et
h
er
th
ey
ar
e
w
el
l
en
o
u
g
h
to
p
ar
ti
ci
p
at
e
o
r
if
th
e
ap
p
ro
ac
h
sh
o
u
ld
b
e
o
n
an
o
th
er
d
ay
(o
r
n
o
t
at
al
l)
.
(b
)
L
et
p
ar
ti
ci
p
an
ts
k
n
o
w
d
is
tr
es
si
n
g
p
h
y
si
ca
l
o
r
em
o
ti
o
n
al
sy
m
p
to
m
s
w
il
l
b
e
re
p
o
rt
ed
to
tr
ea
ti
n
g
cl
in
ic
ia
n
s.
(c
)
P
as
s
cl
in
ic
al
q
u
es
ti
o
n
s
o
n
to
te
am
o
r
en
co
u
ra
g
e
p
ar
ti
ci
p
an
t
to
fo
ll
o
w
u
p
w
it
h
cl
in
ic
ia
n
s.
(d
)
D
o
n
o
t
in
te
rf
er
e
w
it
h
cl
in
ic
al
ca
re
.
F
le
x
ib
le
m
et
h
od
s:
A
st
ra
te
g
y
th
at
in
v
o
lv
es
m
o
d
if
y
in
g
d
at
a
co
ll
ec
ti
o
n
p
ro
ce
d
u
re
s
to
ac
co
m
m
o
d
at
e
p
ar
ti
ci
p
an
t’
s
p
h
y
si
ca
l,
em
o
ti
o
n
al
,
o
r
o
th
er
n
ee
d
s.
‘‘S
o
,
th
at
’s
p
ar
t
o
f
w
h
at
w
e
h
av
e
b
ee
n
w
o
rk
in
g
w
it
h
,
is
cr
ea
ti
n
g
it
so
it
is
st
il
l
ri
g
o
ro
u
s
in
tr
y
in
g
to
g
et
at
th
e
sa
m
e
is
su
es
,
b
u
t
b
ei
n
g
fl
ex
ib
le
to
re
co
g
n
iz
e
th
is
is
n
o
t
a
p
h
ar
m
ac
eu
ti
ca
l
tr
ia
l
an
d
th
at
72
h
o
u
rs
is
n
o
t
n
ea
rl
y
as
im
p
o
rt
an
t
as
m
ak
in
g
su
re
th
at
so
m
eb
o
d
y
w
il
l
ta
lk
to
y
o
u
.’’
N
01
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‘‘O
n
e
o
f
th
em
h
ad
an
ex
p
er
ie
n
ce
o
n
a
te
le
p
h
o
n
e
ca
ll
w
h
er
e
th
e
p
at
ie
n
t
w
as
re
al
ly
v
er
y
,
v
er
y
sh
o
rt
o
f
b
re
at
h
,
h
av
in
g
a
v
er
y
d
if
fi
cu
lt
ti
m
e
g
et
ti
n
g
th
ro
u
g
h
th
e
in
te
rv
ie
w
,
an
d
p
ar
t
o
f
w
h
at
w
e
h
ad
d
o
n
e
to
ad
ju
st
fo
r
an
y
o
f
th
o
se
k
in
d
s
o
f
th
in
g
s
w
as
to
sa
y
w
e
ca
n
st
o
p
at
an
y
p
o
in
t.
W
e
ca
n
ca
ll
b
ac
k
an
d
fi
n
is
h
th
e
in
te
rv
ie
w
la
te
r
to
d
ay
.
W
e
ca
n
ca
ll
to
m
o
rr
o
w
.I
m
ea
n
w
e
w
er
e
v
er
y
fl
ex
ib
le
in
h
o
w
w
e
p
re
se
n
te
d
th
e
in
te
rv
ie
w
.’’
N
03
3S
(a
)
T
ra
ck
an
d
av
o
id
h
o
li
d
ay
s,
b
ir
th
d
ay
s,
d
ea
th
an
n
iv
er
sa
ry
.
(b
)
A
n
ti
ci
p
at
e
n
ee
d
to
re
sc
h
ed
u
le
o
r
p
re
m
at
u
re
ly
en
d
d
at
a
co
ll
ec
ti
o
n
b
as
ed
o
n
p
ar
ti
ci
p
an
t’
s
n
ee
d
s.
(c
)
C
h
ec
k
in
fr
eq
u
en
tl
y
d
u
ri
n
g
d
at
a
co
ll
ec
ti
o
n
an
d
st
o
p
if
p
ar
ti
ci
p
an
t
fa
ti
g
u
ed
o
r
u
p
se
t.
(d
)
C
o
m
p
en
sa
te
re
g
ar
d
le
ss
o
f
w
h
et
h
er
p
ar
ti
ci
p
an
t
co
m
p
le
te
d
su
rv
ey
s/
in
te
rv
ie
w
.
(e
)
M
in
im
iz
e
n
u
m
b
er
,
le
n
g
th
,
an
d
co
m
p
le
x
it
y
o
f
su
rv
ey
in
st
ru
m
en
ts
an
d
in
te
rv
ie
w
s.
(f
)
A
ll
o
w
p
ar
ti
ci
p
an
ts
to
ta
lk
as
lo
n
g
as
th
ey
n
ee
d
.
(g
)
D
ro
p
su
rv
ey
s
o
r
d
at
a
co
ll
ec
ti
o
n
ti
m
e-
p
o
in
ts
to
m
in
im
iz
e
b
u
rd
en
.
(h
)
C
o
n
d
u
ct
d
at
a
co
ll
ec
ti
o
n
at
lo
ca
ti
o
n
m
o
st
co
n
v
en
ie
n
t
to
p
ar
ti
ci
p
an
t.
(i
)
C
o
n
d
u
ct
d
at
a
co
ll
ec
ti
o
n
b
y
p
h
o
n
e
o
r
in
p
er
so
n
d
ep
en
d
in
g
o
n
p
ar
ti
ci
p
an
t
p
re
fe
re
n
ce
s.
(j
)
L
et
p
ar
ti
ci
p
an
t
co
n
tr
o
l
w
h
o
is
in
th
e
ro
o
m
(e
sp
ec
ia
ll
y
if
a
p
at
ie
n
t)
.
(c
on
ti
n
u
ed
)
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(C
o
n
t
in
u
e
d
)
S
tr
at
eg
y
fo
cu
s
S
tr
at
eg
y
ca
te
g
or
ie
s
E
x
em
p
la
r
p
ar
ti
ci
p
an
t
qu
ot
es
S
am
p
le
st
ra
te
g
ie
s
B
ac
ku
p
p
ro
to
co
ls
:
P
la
n
s
th
at
ad
d
re
ss
si
tu
at
io
n
s
w
h
er
e
th
e
p
ar
ti
ci
p
an
t
id
en
ti
fi
es
o
r
ap
p
ea
rs
to
b
e
ex
p
er
ie
n
ci
n
g
p
h
y
si
ca
l,
em
o
ti
o
n
al
,
o
r
sp
ir
it
u
al
h
ar
m
.
F
o
rm
al
iz
ed
as
p
ar
t
o
f
th
e
st
u
d
y
p
ro
to
co
l.
‘‘W
e
h
av
e
a
p
ro
ce
d
u
re
fo
r,
if
w
e
u
p
se
t
an
y
b
o
d
y
,
th
ey
ca
n
g
et
co
u
n
se
li
n
g
re
so
u
rc
es
.
If
th
er
e
ar
e
an
y
re
d
fl
ag
s,
if
so
m
eb
o
d
y
ex
p
re
ss
es
d
u
ri
n
g
th
e
in
te
rv
en
ti
o
n
th
at
th
ey
ar
e
th
in
k
in
g
o
f
su
ic
id
e,
w
e
h
av
e
a
p
ro
ce
d
u
re
to
h
an
d
le
th
at
.T
h
at
’s
al
l
w
el
l
sp
el
le
d
o
u
t.
W
e
h
av
e
a
p
la
n
in
p
la
ce
fo
r
al
l
o
f
th
e
st
u
d
ie
s
li
k
e
th
is
th
at
co
u
ld
u
p
se
t
so
m
eb
o
d
y
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impaired participants. Investigators reported widely varied
IRB policies about the participation of persons with decisional
impairment, but in most settings, proxy consent was permit-
ted by either a strictly defined legally authorized representa-
tive or a more loosely defined surrogate (such as a family
member or domestic partner).
Protocol strategies
Approaching a potentially sensitive topic. Investigators
described using a very active approach to data collection that
involved constant monitoring and adjustment during data
collection. The primary motivation behind this strategy was to
be sensitive to the emotional needs of the patient or caregiver.
This sensitivity included avoiding challenging the patient’s
understanding of his or her condition and caution about in-
advertently imposing the investigator’s values on the situation.
Investigators described starting the survey or interview with
nonthreatening topics to build trust andwith probingquestions
to assess participants’ willingness to engage in conversation
about more sensitive topics such as diagnoses or prognoses.
Interviewswere diplomatically ended or specific items skipped
if a participant signaled he or she was uncomfortable with the
questions or was unwilling to respond. Other investigators
described using very broad questions that allowed the partici-
pant to decide what if any aspects of the interview questions or
survey items were relevant to their situation. Additional strat-
egies included giving participants as much time as needed to
reflect on emotional experiences both during and after the in-
terview and concluding the interview with something more
upbeat. Finally, some investigators reported that they re-
minded people frequently of their right to refuse to answer
questions or to withdraw from the study at any time. For
studies with more than one data collection time point, investi-
gators described assigning the same team member to a partic-
ipant for each time point to help build rapport as well as
minimize the burden of getting used to a new person and style.
Use of language. Investigators considered the use of
language to be very important in developing consent docu-
ments, recruitment materials, and data collection materials,
and described numerous strategies to avoid inadvertently
disclosing prognostic or diagnostic information to partici-
pants. These strategies included inserting language in the
consent form or studymaterials indicating that ‘‘some of these
questions may not apply to you’’ to allow participants who
were troubled by certain words or phrases to maintain the
belief that this language was not relevant to their situation.
Investigators described ‘‘echoing’’ language, meaning they
used certain terms and phrases only when first used by par-
ticipants rather than risk using language that could be dis-
tressing. Specific terms that were commonly avoided in
written materials and in conversation included ‘‘terminal,’’
‘‘death,’’ ‘‘dying,’’ and ‘‘end of life.’’ More general terms such
as ‘‘advanced illness,’’ ‘‘seriously ill,’’ ‘‘critically ill,’’ ‘‘life-
threatening,’’ and ‘‘palliative care’’ were generally viewed as
preferable, though there was no universal agreement about
the acceptability of these terms. Some investigators reported
that IRBs were not as sensitive about the use of language as
they were themselves and provided examples of IRBs re-
quiring the use of terms that investigators felt to be too direct
and potentially upsetting.
Working with clinicians. Investigators who did data
collection in clinical settings worked closely with the clinical
team to avoid interfering with care and to ensure that physi-
cians, nurses, and other members of the treatment team
thought it was appropriate to approach patients for partici-
pation. In some situations, that meant postponing data col-
lection based on either the clinician’s opinion about the
patient’s ability to participate or on what was happening
during that day’s appointment.
Flexible methods. Being sensitive to the needs of
participants required creativity and flexibility. Investigators
reported being flexible about the timing of data collection or
intervention based on the needs of the participant and careful
tracking to ensure they avoided contacting participants on
personally meaningful dates such as holidays, birthdays, or
the date of death anniversary. Data collection time points
were delayed or dropped if necessary to minimize burden
despite the impact on scientific rigor. Missing data were dealt
with in the analytic phase. In designing the study, investiga-
tors were careful to minimize the number, length, and com-
plexity of instruments. Participants were allowed to decide
whether theywished to be interviewed by phone or in person,
whether they wished to read survey questions or have the
items read out loud, where they preferred data collection to
occur, and who they wanted in the room. Investigators de-
scribed using real-time feedback to determine whether the
participant was fatigued or upset, even if it resulted in ter-
minating data collection prematurely.
Backup protocols. Investigators were very clear that
they were engaging with participants as researchers rather
than clinicians but described feeling a strong sense of re-
sponsibility to intervene when participants seemed to be
emotionally or physically distressed. Backup protocols con-
sisting of contingency plans for addressing participant dis-
tress were viewed favorably by most investigators and even
required by some IRBs as an acceptable way to minimize risk.
A backup protocol could be triggered when a study partici-
pant was observed to be in distress as a result of study par-
ticipation (e.g., emotional distress) or due to an underlying,
preexisting condition (e.g., untreated pain). The distress was
recognized both through the use of objective ‘‘cut points’’ on
study instruments and with more subjective observations.
Some backup protocols involved asking the patient to share
information with his or her clinician (for less urgent issues),
notifying the participant’s clinical care providers about the
concern, providing a list of community resources, directly
referring the patient to a resource such as mental health ser-
vices, or delivering mental health services crisis intervention
through experts affiliated with the research team. Con-
fidentiality concerns were mitigated by notifying participants
during the consent process about the existence of backup
protocols. For many, the use of backup plans, such as report-
ing high levels of symptom distress in an observational study,
represented a tradeoff with scientific rigor that was viewed as
methodologically challenging but ethically necessary.
Research staff strategies. Many investigators ex-
pressed concerns that research with seriously ill and dying
populations is challenging and emotionally laden. Therefore,
hiring research staff who had previously worked with the
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study population in some capacity was highly valued. This
helped ensure consent was sensitively obtained and it pro-
vided some reassurance that research staff had the necessary
clinical expertise to be responsive to signs of distress. When it
was not possible to hire staff with prior experience, investiga-
tors described careful training plans to develop the necessary
skills. Additionally, investigators expressed concerns that it
was not realistic to expect staff to fully understand the exis-
tential implications of doing research with seriously ill and
dying populations, so applicants were carefully screened for
their ability to manage stress. Investigators also described
providing research staff with emotional support to help pro-
cess their reactions to what they were hearing or observing
during the course of data collection. When possible, more than
one data collector was hired to provide a natural outlet for staff
to informally share experiences. Strategies included encour-
aged research staff to journal and do additional reading about
grief and bereavement; holding team meetings (including via
phone for multisite studies) to process emotions and discuss
challenging participants; including professional counselors in
team meetings; referring to counselors for individual sessions;
encouraging the use of alternative therapies for self-care;
facilitating access to an expert consultant; and forming a project
staff support group. In the best case scenario, fundingwas built
into the study budget to provide some of these services.
Meta-themes
The strategies described above share the common, over-
arching meta-themes of compassion and vigilance. The concept
of compassion was reflected in strategies that represented
heightened sensitivity to the needs of the population such as
allowing extra time to solicit consent, gently building up to
sensitive questions, developing backup protocols, careful
attention to the use of language, and methodological flexibil-
ity. Compassion was coupled with exercising heightened
vigilance during every step of the research process about the
possible effects of study participation on the participants’
emotional and physical well-being, ensuring the research did
not interfere with clinical care, and being attentive to the
emotional needs of research staff. Investigators were fully
committed to protecting human subjects and creative in the de-
velopment of strategies to mitigate the potential risk of harm.
Discussion
Palliative and end-of-life investigators described a range of
strategies sharing the underlying themes of compassion and
vigilance that minimize ethical concerns in the course of recruit-
ing, consenting, and conducting research with seriously ill pa-
tients and their family members. The strategies described by
investigators reflect efforts to balance the principles of respect for
patient autonomy, beneficence, and justice with the goal of min-
imizing negative outcomes related to research participation.37
However, achieving a balance among these ethical princi-
ples often necessitates methodological and ethical tradeoffs.
Most investigators reported that they obtained consent from
treating clinicians prior to contacting potential participants,
and several expressed the belief that this approach helps
minimize the risk of harm and facilitates research by allowing
clinicians to screen out patients who are too distressed or
otherwise inappropriate for research. However, clinicians
who are opposed to the research may act as gatekeepers and
impede recruitment, limiting the applicability of study find-
ings, or may leave patients feeling pressured to partici-
pate.7,15,37,38 Remaining flexible about study procedures
allows investigators to meet the needs of seriously ill patients
and potentially bereaved family members and increases op-
portunities for participation.6,37 However, being too flexible
can result in a loss of generalizability and power,15 which
limits the value of the research.
Investigators proposing research with seriously ill patients
and family members need to anticipate challenges such as
these and proactively plan tominimize the impact of tradeoffs
by building in procedures to reduce the effects of gatekeeping,
developing alternative recruitment sites, crafting backup
protocols to manage distressing symptoms, and devising
plans for managing missing data.6 If investigators are not
attentive to these challenges in the course of the study design,
it could impact the success of projects and ultimately raise
concerns about the validity of this area of science.7 These
concerns also suggest it is important that IRB applications and
grant proposals be reviewed by individuals with appropriate
expertise who are able to evaluate whether proposed studies
are both sensitive to the needs of the population and address
potential methodological limitations that could impact the
usefulness of study findings.
A key limitation of this study is that the findings represent
only the experiences of those investigators who agreed to be
interviewed. Although efforts were made to include research
that reflected a broad array of end-of-life and palliative care
issues, the experiences and perceptions of the study partici-
pants may be different from those of people not invited or
unwilling to participate in the study. Additionally, the in-
vestigators who were interviewed were on average a highly
experienced group of researchers who developed strategies
over time through a program of research, and newer inves-
tigators may not be as adept at managing ethical concerns.
Findings suggest that investigators who do research with
seriously ill patients and family members are creative in
managing ethical concerns through compassionate and vigi-
lant strategies. The identification of commonly used, suc-
cessful strategies may be useful in developing evidence-based
standards for evaluating research with palliative and end-
of-life care populations. Although IRBs vary in their inter-
pretation of federal policy for the protection of human
subjects and the Health Insurance Portability and Account-
ability Act of 1996 (HIPAA), many of these strategies can be
adapted to fit local conditions in order to address ethical
concerns and minimize barriers to the development of palli-
ative and end-of-life care science.
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